Tryptanthrin
AlkaPlorer ID: AK001733
Synonym: None
IUPAC Name: indolo[2,1-b]quinazoline-6,12-dione
Structure
SMILES: O=C1C2=CC=CC=C2N2C1=NC1=CC=CC=C1C2=O
InChI: InChI=1S/C15H8N2O2/c18-13-10-6-2-4-8-12(10)17-14(13)16-11-7-3-1-5-9(11)15(17)19/h1-8H
InChIKey: VQQVWGVXDIPORV-UHFFFAOYSA-N
Reference
PubChem CID: 73549
CAS: 13220-57-0
LOTUS: LTS0210698
SuperNatural Ⅲ: SN0397485
COCONUT: CNP0271812
data_source: manually
Source
| Species | Genus | Family | Order | Class | Phylum | Kingdom | Domain |
|---|---|---|---|---|---|---|---|
| Persicaria tinctoria | Persicaria | Polygonaceae | Caryophyllales | Magnoliopsida | Streptophyta | Viridiplantae | Eukaryota |
Properties Information
Molecule Weight: 248.241
TPSA?: 51.96
MolLogP?: 1.9301
Number of H-Donors: 0
Number of H-Acceptors: 4
RingCount: 4
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Chlorocebus sabaeus | Vero | IC50 | 8.0 | ug.mL-1 | 10.1021/np3007167 |
| Chlorocebus sabaeus | Vero | IC50 | 100.0 | ug.mL-1 | 10.1021/acs.jnatprod.8b00567 |
| Electrophorus electricus | Acetylcholinesterase | Inhibition | 35.31 | % | 10.1016/j.bmc.2012.09.040 |
| Equus caballus | Cholinesterase | Inhibition | -2.13 | % | 10.1016/j.bmc.2012.09.040 |
| Escherichia coli | Escherichia coli | GI | nan | None | 10.1021/jm901847f |
| Escherichia coli | Escherichia coli | GI50 | 2.25 | ug.mL-1 | 10.1021/jm901847f |
| Escherichia coli K-12 | Beta-lactamase AmpC | Potency | 891.3 | nM | None |
| Giardia intestinalis | Putative fructose-1,6-bisphosphate aldolase | Potency | 6294.6 | nM | None |
| Giardia intestinalis | Putative fructose-1,6-bisphosphate aldolase | Potency | 7062.7 | nM | None |
| Giardia intestinalis | Putative fructose-1,6-bisphosphate aldolase | Potency | 7924.5 | nM | None |
| Homo sapiens | 786-0 | GI50 | 28248.8 | nM | None |
| Homo sapiens | A498 | GI50 | 950.0 | nM | 10.1016/s0960-894x(02)00431-6 |
| Homo sapiens | A498 | GI50 | 18155.16 | nM | None |
| Homo sapiens | A549 | Activity | nan | None | 10.1021/np3002833 |
| Homo sapiens | A549 | GI50 | 2588.21 | nM | None |
| Homo sapiens | ACHN | GI50 | 1995.26 | nM | None |
| Homo sapiens | Arachidonate 5-lipoxygenase | IC50 | 150.0 | nM | 10.1016/j.bmc.2012.06.034 |
| Homo sapiens | Arachidonate 5-lipoxygenase | IC50 | 200000.0 | nM | 10.1016/j.bmc.2017.07.003 |
| Homo sapiens | ATPase family AAA domain-containing protein 5 | Potency | 1635.3 | nM | None |
| Homo sapiens | Bel-7402 | Activity | nan | None | 10.1021/np3002833 |
| Homo sapiens | BGC-823 | Activity | nan | None | 10.1021/np3002833 |
| Homo sapiens | BT-549 | GI50 | 14554.59 | nM | None |
| Homo sapiens | Caco-2 | permeability | 225.0 | ucm/s | 10.1021/np3007167 |
| Homo sapiens | Caco-2 | permeability | 601.0 | ucm/s | 10.1021/np3007167 |
| Homo sapiens | Caco-2 | Ratio | 1.0 | None | 10.1021/np3007167 |
| Homo sapiens | CAKI-1 | GI50 | 12331.05 | nM | None |
| Homo sapiens | Canalicular multispecific organic anion transporter 1 | Inhibition | 30.0 | % | 10.1016/j.ejmech.2017.06.047 |
| Homo sapiens | CCRF-CEM | GI50 | 9078.21 | nM | None |
| Homo sapiens | CCRF-CEM | GI50 | 14470.0 | nM | 10.1016/j.ejmech.2020.112504 |
| Homo sapiens | CCRF-CEM | IC50 | 44360.0 | nM | 10.1016/j.ejmech.2020.112504 |
| Homo sapiens | c-Jun N-terminal kinase 1 | Kd | 23000.0 | nM | 10.1016/j.ejmech.2018.10.023 |
| Homo sapiens | c-Jun N-terminal kinase 2 | Activity | nan | None | 10.1016/j.ejmech.2018.10.023 |
| Homo sapiens | c-Jun N-terminal kinase 3 | Activity | nan | None | 10.1016/j.ejmech.2018.10.023 |
| Homo sapiens | c-Jun N-terminal kinase, JNK | Inhibition | nan | % | 10.1016/j.ejmech.2018.10.023 |
| Homo sapiens | COLO 205 | GI50 | 12764.39 | nM | None |
| Homo sapiens | Cyclooxygenase-2 | IC50 | 64.0 | nM | 10.1016/j.bmc.2012.06.034 |
| Homo sapiens | Cyclooxygenase-2 | IC50 | 64.0 | nM | 10.1016/j.bmc.2012.09.069 |
| Homo sapiens | Cyclooxygenase-2 | IC50 | 64.0 | nM | 10.1021/np049655u |
| Homo sapiens | Cytochrome P450 2C19 | Inhibition | 9.0 | % | 10.1021/np3007167 |
| Homo sapiens | Cytochrome P450 2C9 | Inhibition | 25.0 | % | 10.1021/np3007167 |
| Homo sapiens | Cytochrome P450 3A4 | Inhibition | 12.0 | % | 10.1021/np3007167 |
| Homo sapiens | DNA polymerase iota | Potency | 89125.1 | nM | None |
| Homo sapiens | DNA topoisomerase I | Inhibition | nan | % | 10.1021/jm901847f |
| Homo sapiens | DNA topoisomerase II alpha | Inhibition | 4.54 | % | 10.1016/j.bmc.2012.06.034 |
| Homo sapiens | DNA topoisomerase II alpha | Inhibition | nan | % | 10.1016/j.ejmech.2020.112504 |
| Homo sapiens | DU-145 | GI50 | 400.0 | nM | 10.1016/s0960-894x(02)00431-6 |
| Homo sapiens | DU-145 | GI50 | 10690.55 | nM | None |
| Homo sapiens | DU-145 | IC50 | 6220.0 | nM | 10.1016/j.bmc.2012.06.034 |
| Homo sapiens | EKVX | GI50 | 13427.65 | nM | None |
| Homo sapiens | Geminin | Potency | 1158.2 | nM | None |
| Homo sapiens | Glucose transporter | Inhibition | -2.52 | % | 10.6019/CHEMBL3433997 |
| Homo sapiens | HCC 2998 | GI50 | 29376.5 | nM | None |
| Homo sapiens | HCT-116 | GI50 | 5861.38 | nM | None |
| Homo sapiens | HCT-15 | GI50 | 3597.49 | nM | None |
| Homo sapiens | HCT-15 | IC50 | 8490.0 | nM | 10.1016/j.bmc.2012.06.034 |
| Homo sapiens | HCT-8 | Activity | nan | None | 10.1021/np3002833 |
| Homo sapiens | HEK293 | IC50 | 4110.0 | nM | 10.1016/j.bmc.2012.06.034 |
| Homo sapiens | HepG2 | IC50 | 0.3054 | ug.mL-1 | 10.1021/jm501809x |
| Homo sapiens | HepG2 | IC50 relative | 4300.0 | nM | 10.6019/EOS300108 |
| Homo sapiens | HepG2 | Inhibition | 9.0 | % | 10.1038/nature09107 |
| Homo sapiens | HepG2 | Potency | 3981.1 | nM | None |
| Homo sapiens | HFF | TD50 | 6.4 | uM | 10.1016/j.bmcl.2012.12.024 |
| Homo sapiens | Histone acetyltransferase GCN5 | Potency | 10000.0 | nM | None |
| Homo sapiens | Histone deacetylase 6 | IC50 | 3286.0 | nM | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | 68.59 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | 82.69 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | 103.79 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone-lysine N-methyltransferase MLL | Potency | 31622.8 | nM | None |
| Homo sapiens | HL-60 | GI50 | 3706.81 | nM | None |
| Homo sapiens | HL-60 | IC50 | 2000.0 | nM | 10.1016/j.bmc.2017.07.003 |
| Homo sapiens | HL-60 | IC50 | 5000.0 | nM | 10.1016/j.bmc.2017.07.003 |
| Homo sapiens | HOP-62 | GI50 | 12133.89 | nM | None |
| Homo sapiens | HOP-92 | GI50 | 44463.13 | nM | None |
| Homo sapiens | Hs-578T | GI50 | 17139.57 | nM | None |
| Homo sapiens | HT-1376 | Activity | 10.0 | uM | 10.1016/j.bmc.2012.06.034 |
| Homo sapiens | HT-29 | GI50 | 14757.07 | nM | None |
| Homo sapiens | Huh-7 | CC50 | 10000.0 | nM | 10.1073/pnas.0802982105 |
| Homo sapiens | Huntingtin | Potency | 11220.2 | nM | None |
| Homo sapiens | IGROV-1 | GI50 | 23014.42 | nM | None |
| Homo sapiens | Indoleamine 2,3-dioxygenase | IC50 | 53.7 | nM | 10.1021/jm401195n |
| Homo sapiens | Indoleamine 2,3-dioxygenase | IC50 | 7150.0 | nM | 10.1021/jm401195n |
| Homo sapiens | Indoleamine 2,3-dioxygenase | IC50 | 7150.0 | nM | None |
| Homo sapiens | Indoleamine 2,3-dioxygenase | IC50 | 498700.0 | nM | 10.1016/j.bmc.2017.07.003 |
| Homo sapiens | Indoleamine 2,3-dioxygenase | IC50 | 53700000.0 | nM | None |
| Homo sapiens | Indoleamine 2,3-dioxygenase | Ki | 4810.0 | nM | 10.1021/jm401195n |
| Homo sapiens | Indoleamine 2,3-dioxygenase | Ki | 4810.0 | nM | None |
| Homo sapiens | Indoleamine 2,3-dioxygenase 2 | IC50 | 5000.0 | nM | 10.1016/j.ejmech.2016.07.013 |
| Homo sapiens | Indoleamine 2,3-dioxygenase 2 | IC50 | 5010.0 | nM | None |
| Homo sapiens | Indoleamine 2,3-dioxygenase 2 | IC50 | 17300.0 | nM | 10.1016/j.ejmech.2016.07.013 |
| Homo sapiens | Indoleamine 2,3-dioxygenase 2 | IC50 | 17310.0 | nM | None |
| Homo sapiens | Indoleamine 2,3-dioxygenase 2 | Inhibition | 18.0 | % | None |
| Homo sapiens | Indoleamine 2,3-dioxygenase 2 | Inhibition | nan | % | 10.1016/j.ejmech.2016.07.013 |
| Homo sapiens | Indoleamine 2,3-dioxygenase 2 | Ki | 15180.0 | nM | None |
| Homo sapiens | Indoleamine 2,3-dioxygenase 2 | Ki | 15200.0 | nM | 10.1016/j.ejmech.2016.07.013 |
| Homo sapiens | Indoleamine 2,3-dioxygenase 2 | Ratio IC50 | 29.7 | None | 10.1016/j.ejmech.2016.07.013 |
| Homo sapiens | K562 | Activity | 21.9 | % | 10.1016/j.bmc.2017.07.003 |
| Homo sapiens | K562 | Activity | 33.4 | % | 10.1016/j.bmc.2017.07.003 |
| Homo sapiens | K562 | Activity | 52.2 | % | 10.1016/j.bmc.2017.07.003 |
| Homo sapiens | K562 | GI50 | 3184.2 | nM | None |
| Homo sapiens | K562 | IC50 | 8.8 | ug.mL-1 | 10.1016/j.bmc.2017.07.003 |
| Homo sapiens | K562 | IC50 | 5000.0 | nM | 10.1016/j.bmc.2017.07.003 |
| Homo sapiens | K562 | IC50 | 15000.0 | nM | 10.1016/j.bmc.2017.07.003 |
| Homo sapiens | KETR3 | Activity | nan | None | 10.1021/np3002833 |
| Homo sapiens | KM12 | GI50 | 6622.17 | nM | None |
| Homo sapiens | Liver microsomes | Stability | 15.0 | % | 10.1021/np3007167 |
| Homo sapiens | LOX IMVI | GI50 | 4436.09 | nM | None |
| Homo sapiens | M14 | GI50 | 5649.37 | nM | None |
| Homo sapiens | M14 | GI50 | 15000.0 | nM | 10.1016/s0960-894x(02)00431-6 |
| Homo sapiens | Malme-3M | GI50 | 13396.77 | nM | None |
| Homo sapiens | MCF7 | Activity | nan | None | 10.1021/np3002833 |
| Homo sapiens | MCF7 | GI50 | 7194.49 | nM | None |
| Homo sapiens | MCF7 | IC50 | 580.0 | nM | 10.1016/j.bmc.2017.07.003 |
| Homo sapiens | MCF7 | IC50 | 11100.0 | nM | 10.1021/np800064w |
| Homo sapiens | MDA-MB-231 | GI50 | 16672.47 | nM | None |
| Homo sapiens | MDA-MB-435 | GI50 | 1853.53 | nM | None |
| Homo sapiens | MDA-N | GI50 | 18197.01 | nM | None |
| Homo sapiens | Microtubule-associated protein tau | Potency | 17782.8 | nM | None |
| Homo sapiens | MOLT-4 | GI50 | 7943.28 | nM | None |
| Homo sapiens | MOLT-4 | IC50 | 8000.0 | nM | 10.1016/j.bmc.2017.07.003 |
| Homo sapiens | MOLT-4 | IC50 | 10000.0 | nM | 10.1016/j.bmc.2017.07.003 |
| Homo sapiens | Mothers against decapentaplegic homolog 3 | Potency | 3162.3 | nM | None |
| Homo sapiens | Muscleblind-like protein 1 | Potency | 1412.5 | nM | None |
| Homo sapiens | NCI/ADR-RES | GI50 | 22335.72 | nM | None |
| Homo sapiens | NCI/ADR-RES | GI50 | 30000.0 | nM | 10.1016/s0960-894x(02)00431-6 |
| Homo sapiens | NCI/ADR-RES | IC50 | 30.0 | nM | 10.1016/j.bmc.2017.07.003 |
| Homo sapiens | NCI-H226 | GI50 | 30902.95 | nM | None |
| Homo sapiens | NCI-H23 | GI50 | 9727.47 | nM | None |
| Homo sapiens | NCI-H322M | GI50 | 11324.0 | nM | None |
| Homo sapiens | NCI-H460 | GI50 | 1435.49 | nM | None |
| Homo sapiens | NCI-H460 | IC50 | 9000.0 | nM | 10.1021/np800064w |
| Homo sapiens | NCI-H522 | GI50 | 15000.0 | nM | 10.1016/s0960-894x(02)00431-6 |
| Homo sapiens | NCI-H522 | GI50 | 15346.17 | nM | None |
| Homo sapiens | Nerve growth factor receptor Trk-A | Kd | 9200.0 | nM | 10.1016/j.ejmech.2018.10.023 |
| Homo sapiens | Neurotrophic tyrosine kinase receptor type 2 | Kd | 7200.0 | nM | 10.1016/j.ejmech.2018.10.023 |
| Homo sapiens | Niemann-Pick C1 protein | Potency | 2818.4 | nM | None |
| Homo sapiens | Nuclear factor erythroid 2-related factor 2 | Potency | 5173.5 | nM | None |
| Homo sapiens | Nuclear factor erythroid 2-related factor 2 | Potency | 6513.1 | nM | None |
| Homo sapiens | OVCAR-3 | GI50 | 4539.42 | nM | None |
| Homo sapiens | OVCAR-4 | GI50 | 19054.61 | nM | None |
| Homo sapiens | OVCAR-5 | GI50 | 15995.58 | nM | None |
| Homo sapiens | OVCAR-8 | GI50 | 5794.29 | nM | None |
| Homo sapiens | Parathyroid hormone receptor | Potency | 3162.3 | nM | None |
| Homo sapiens | PC-3 | GI50 | 648.63 | nM | None |
| Homo sapiens | Plasma | PPB | 95.9 | % | 10.1021/np3007167 |
| Homo sapiens | Prelamin-A/C | Potency | 354.8 | nM | None |
| Homo sapiens | Ras-related protein Rab-9A | Potency | 3162.3 | nM | None |
| Homo sapiens | RPMI-8226 | GI50 | 1039.92 | nM | None |
| Homo sapiens | RXF 393 | GI50 | 28054.34 | nM | None |
| Homo sapiens | SF-268 | GI50 | 19906.73 | nM | None |
| Homo sapiens | SF-268 | IC50 | 24400.0 | nM | 10.1021/np800064w |
| Homo sapiens | SF-295 | GI50 | 4285.49 | nM | None |
| Homo sapiens | SF-539 | GI50 | 20749.14 | nM | None |
| Homo sapiens | SK-MEL-2 | GI50 | 10092.53 | nM | None |
| Homo sapiens | SK-MEL-28 | GI50 | 15812.48 | nM | None |
| Homo sapiens | SK-MEL-5 | GI50 | 13122.0 | nM | None |
| Homo sapiens | SK-OV-3 | GI50 | 2500.0 | nM | 10.1016/s0960-894x(02)00431-6 |
| Homo sapiens | SK-OV-3 | GI50 | 100000.0 | nM | None |
| Homo sapiens | SN12C | GI50 | 12618.28 | nM | None |
| Homo sapiens | SNB-19 | GI50 | 25003.45 | nM | None |
| Homo sapiens | SNB-75 | GI50 | 30831.88 | nM | None |
| Homo sapiens | SR | GI50 | 8472.27 | nM | None |
| Homo sapiens | SW-620 | GI50 | 5000.0 | nM | 10.1016/s0960-894x(02)00431-6 |
| Homo sapiens | SW-620 | GI50 | 20796.97 | nM | None |
| Homo sapiens | T47D | GI50 | 8871.56 | nM | None |
| Homo sapiens | T47D | IC50 | 14290.0 | nM | 10.1016/j.bmc.2012.06.034 |
| Homo sapiens | TK-10 | GI50 | 43251.38 | nM | None |
| Homo sapiens | Tryptophan 2,3-dioxygenase | IC50 | 140.0 | nM | 10.1016/j.ejmech.2018.10.017 |
| Homo sapiens | Tryptophan 2,3-dioxygenase | IC50 | 194.0 | nM | 10.1016/j.ejmech.2018.10.017 |
| Homo sapiens | Tryptophan 2,3-dioxygenase | IC50 | 900.0 | nM | 10.1016/j.bmc.2019.02.014 |
| Homo sapiens | Tryptophan 2,3-dioxygenase | IC50 | 3940.0 | nM | 10.1016/j.ejmech.2018.10.017 |
| Homo sapiens | Tryptophan 2,3-dioxygenase | Ki | 581.0 | nM | 10.1016/j.ejmech.2018.10.017 |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 461.1 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 517.4 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 1299.5 | nM | None |
| Homo sapiens | U-251 | GI50 | 3341.95 | nM | None |
| Homo sapiens | U-251 | GI50 | 100000.0 | nM | 10.1016/s0960-894x(02)00431-6 |
| Homo sapiens | UACC-257 | GI50 | 3019.95 | nM | None |
| Homo sapiens | UACC-62 | GI50 | 3689.78 | nM | None |
| Homo sapiens | UO-31 | GI50 | 5058.25 | nM | None |
| Human alphaherpesvirus 1 | Human alphaherpesvirus 1 | Activity | nan | None | 10.1021/np3002833 |
| Human immunodeficiency virus 1 | Aberrant vpr protein | Potency | 3548.1 | nM | None |
| Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Activity | nan | None | 10.1021/np3002833 |
| Influenza A virus | Nonstructural protein 1 | Potency | 1122.0 | nM | None |
| Leishmania mexicana | Glucose transporter | Inhibition | -3.28 | % | 10.6019/CHEMBL3433997 |
| Malassezia furfur | Malassezia furfur | MIC | 4.0 | ug.mL-1 | 10.1016/j.bmc.2017.07.003 |
| Mus musculus | Lewis lung carcinoma cell line | Inhibition | nan | % | 10.1021/jm401195n |
| Mus musculus | Nuclear receptor ROR-gamma | Potency | 11220.2 | nM | None |
| Mycobacterium avium | Mycobacterium avium | MIC | 4.0 | ug.mL-1 | 10.1016/j.bmcl.2015.07.057 |
| Mycobacterium tuberculosis | Mycobacterium tuberculosis | MBC90 | 1.0 | ug ml-1 | 10.1021/np3007167 |
| Mycobacterium tuberculosis | Mycobacterium tuberculosis | MIC | 1.6e-05 | ug.mL-1 | 10.1016/j.ejmech.2017.06.005 |
| Mycobacterium tuberculosis | Mycobacterium tuberculosis | MIC | 0.5 | ug.mL-1 | 10.1016/j.bmcl.2015.07.057 |
| Mycobacterium tuberculosis | Mycobacterium tuberculosis | MIC | 1.0 | ug.mL-1 | 10.1016/j.bmcl.2015.07.057 |
| Mycobacterium tuberculosis | Mycobacterium tuberculosis | MIC | 1.0 | ug.mL-1 | 10.1021/acs.jnatprod.8b00567 |
| Mycobacterium tuberculosis | Mycobacterium tuberculosis | MIC | 1.0 | ug.mL-1 | 10.1021/np3007167 |
| Mycobacterium tuberculosis | Mycobacterium tuberculosis | MIC | 10.0 | ug.mL-1 | 10.1016/j.bmc.2012.06.034 |
| Mycobacterium tuberculosis | Mycobacterium tuberculosis | MIC>90 | 7.59 | ug ml-1 | 10.1021/acs.jnatprod.8b00567 |
| Mycobacterium tuberculosis | Protein RecA | EC50 | 643.0 | nM | None |
| Mycobacterium tuberculosis | Replicative DNA helicase | AC50 | 1078.0 | nM | None |
| Mycobacterium tuberculosis | Replicative DNA helicase | AC50 | 380000.0 | nM | None |
| Mycolicibacterium smegmatis | Mycolicibacterium smegmatis | MIC | 6.0 | ug.mL-1 | 10.1016/j.bmcl.2015.07.057 |
| Photinus pyralis | Luciferin 4-monooxygenase | Potency | 21331.3 | nM | None |
| Plasmodium falciparum | Hexose transporter 1 | Inhibition | -2.55 | % | 10.6019/CHEMBL3433997 |
| Plasmodium falciparum | Plasmodium falciparum | AbsAC35 | 0.0617 | uM | None |
| Plasmodium falciparum | Plasmodium falciparum | AbsAC35 | 0.181 | uM | None |
| Plasmodium falciparum | Plasmodium falciparum | Activity | 100.0 | ng/ml | 10.1016/j.ejmech.2021.113400 |
| Plasmodium falciparum | Plasmodium falciparum | EC50 | 211.7 | nM | 10.1073/pnas.0802982105 |
| Plasmodium falciparum | Plasmodium falciparum | EC50 | 275.6 | nM | 10.1073/pnas.0802982105 |
| Plasmodium falciparum | Plasmodium falciparum | IC50 | 0.069 | ug.mL-1 | 10.1016/j.ejmech.2021.113400 |
| Plasmodium falciparum | Plasmodium falciparum | IC50 | 114.0 | nM | 10.1016/j.ejmech.2021.113400 |
| Plasmodium falciparum | Plasmodium falciparum | IC50 | 288.0 | nM | 10.1016/j.ejmech.2021.113400 |
| Plasmodium falciparum | Plasmodium falciparum | Inhibition | 4.0 | % | 10.1038/nature09107 |
| Plasmodium falciparum | Plasmodium falciparum | Inhibition | 80.0 | % | 10.1038/nature09107 |
| Plasmodium falciparum | Plasmodium falciparum | Inhibition | 93.0 | % | 10.1038/nature09107 |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 3.7 | nM | None |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 329.4 | nM | None |
| Plasmodium falciparum | Plasmodium falciparum | XC50 | 856.44 | nM | 10.1038/nature09107 |
| Plasmodium falciparum 3D7 | HSP40, subfamily A, putative | AbsAC1000_uM | 1.835 | uM | None |
| Plasmodium yoelii | Plasmodium yoelii | Activity | nan | None | 10.1126/science.1211936 |
| Plasmodium yoelii | Plasmodium yoelii | IC50 | 225.1 | nM | 10.1126/science.1211936 |
| Plasmodium yoelii | Plasmodium yoelii | Schizont size | 89.55 | um | 10.1126/science.1211936 |
| Rattus norvegicus | Rattus norvegicus | Cmax | 7613599742.18 | nM | 10.1021/np3007167 |
| Rattus norvegicus | Rattus norvegicus | Cmax | 10554302288.11 | nM | 10.1021/np3007167 |
| Rattus norvegicus | Rattus norvegicus | Inhibition | 41.0 | % | 10.1016/j.bmc.2017.07.003 |
| Rattus norvegicus | Rattus norvegicus | Inhibition | 42.0 | % | 10.1016/j.bmc.2017.07.003 |
| Rattus norvegicus | Rattus norvegicus | Inhibition | 46.0 | % | 10.1016/j.bmc.2017.07.003 |
| Rattus norvegicus | Rattus norvegicus | Inhibition | 80.0 | % | 10.1016/j.bmc.2017.07.003 |
| Rattus norvegicus | Rattus norvegicus | T1/2 | 4.35 | hr | 10.1021/np3007167 |
| Rattus norvegicus | Rattus norvegicus | T1/2 | 5.6 | hr | 10.1021/np3007167 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 10.32 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 21.13 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -0.17 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -0.08 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 9.2 | % | 10.21203/rs.3.rs-23951/v1 |
| Staphylococcus aureus | Staphylococcus aureus | MIC | 0.5 | ug.mL-1 | 10.1016/j.bmc.2017.07.003 |
| Toxoplasma gondii | Toxoplasma gondii | ID50 | 0.031 | uM | 10.1128/aac.00903-08 |
| Toxoplasma gondii | Toxoplasma gondii | ID50 | 0.14 | uM | 10.1016/j.bmcl.2012.12.024 |
| None | ADMET | TD50 | 62.0 | uM | 10.1128/aac.00903-08 |
| None | ADMET | TI | 45.0 | None | 10.1016/j.bmcl.2012.12.024 |
| None | ADMET | TI | 2000.0 | None | 10.1128/aac.00903-08 |
| None | No relevant target | Activity | nan | None | 10.1021/jm401195n |
| None | No relevant target | LogD | 2.29 | None | 10.1021/np3007167 |
| None | No relevant target | Solubility | 5400.0 | nM | 10.1021/np3007167 |
| None | No relevant target | Solubility | 11700.0 | nM | 10.1021/np3007167 |
| None | No relevant target | Solubility | 12900.0 | nM | 10.1021/np3007167 |
| None | No relevant target | Solubility | 91020.0 | nM | 10.1016/j.ejmech.2020.112504 |
| None | Unchecked | Activity | nan | None | 10.1021/np500108r |
| None | Unchecked | CC50 | 17498.0 | nM | None |
| None | Unchecked | CC50 | 20000.0 | nM | None |
| None | Unchecked | Flu intensity | 2740.0 | None | 10.1016/j.bmc.2017.07.003 |
| None | Unchecked | Flu intensity | 2826.0 | None | 10.1016/j.bmc.2017.07.003 |
| None | Unchecked | IC50 | 195.0 | nM | None |
| None | Unchecked | IC50 | 330.0 | nM | None |
| None | Unchecked | IC50 | 2800.0 | nM | None |
| None | Unchecked | IFI | 2.19 | % | 10.1073/pnas.0802982105 |
| None | Unchecked | IFI | 2.99 | % | 10.1038/nature09107 |
| None | Unchecked | Inhibition | 4.09 | % | 10.1016/j.bmc.2012.06.034 |
| None | Unchecked | Inhibition | 30.0 | % | 10.1016/j.ejmech.2017.06.047 |
| None | Unchecked | Inhibition | 68.44 | % | 10.1016/j.bmc.2012.06.034 |
| None | Unchecked | Inhibition | 70.0 | % | 10.1016/j.bmc.2017.07.003 |
| None | Unchecked | Potency | 501.2 | nM | None |
| None | Unchecked | Potency | 707.9 | nM | None |
| None | Unchecked | Potency | 2511.9 | nM | None |
| None | Unchecked | Potency | 8912.5 | nM | None |
| None | Unchecked | Potency | 10000.0 | nM | None |
| None | Unchecked | Potency | 11220.2 | nM | None |
| None | Unchecked | Potency | 16360.1 | nM | None |
